{"nct_id":"NCT02658214","title":"Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors","status":"COMPLETED","status_verified_date":"2020-08","start_date":"2016-04-28","start_date_type":"ACTUAL","primary_completion_date":"2019-11-14","primary_completion_date_type":"ACTUAL","completion_date":"2019-11-14","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AZN"]}